LumiraDx Investor Presentation Deck

lumiraDx™ LumiraDx Key Building Blocks Blockbuster Product: HS Troponin 20%-25% of Total Revenue Cardiovascular Represents >$1 billion run-rate revenue (Q4 2025 projected ryn-rate) Blockbuster Product: HbA1c 10%-15% Diabetes 10% Coagulation Blockbuster Product: Flu, COVID, Strep A 20%-25% Respiratory 10% Inflammation Copyright © 2022 LumiraDx Ltd. All Rights Reserved. Worldwide 5% Global Health 10%-25% Other 50

View entire presentation